100 related articles for article (PubMed ID: 26024595)
41. Histone deacetylase inhibition down-regulates cyclin D1 transcription by inhibiting nuclear factor-kappaB/p65 DNA binding.
Hu J; Colburn NH
Mol Cancer Res; 2005 Feb; 3(2):100-9. PubMed ID: 15755876
[TBL] [Abstract][Full Text] [Related]
42. E2F1 enhances glycolysis through suppressing Sirt6 transcription in cancer cells.
Wu M; Seto E; Zhang J
Oncotarget; 2015 May; 6(13):11252-63. PubMed ID: 25816777
[TBL] [Abstract][Full Text] [Related]
43. Msx3 protein recruits histone deacetylase to down-regulate the Msx1 promoter.
Mehra-Chaudhary R; Matsui H; Raghow R
Biochem J; 2001 Jan; 353(Pt 1):13-22. PubMed ID: 11115394
[TBL] [Abstract][Full Text] [Related]
44. Overexpression of histone deacetylase HDAC1 modulates breast cancer progression by negative regulation of estrogen receptor alpha.
Kawai H; Li H; Avraham S; Jiang S; Avraham HK
Int J Cancer; 2003 Nov; 107(3):353-8. PubMed ID: 14506733
[TBL] [Abstract][Full Text] [Related]
45. The zinc finger repressor, ZBP-89, recruits histone deacetylase 1 to repress vimentin gene expression.
Wu Y; Zhang X; Salmon M; Zehner ZE
Genes Cells; 2007 Aug; 12(8):905-18. PubMed ID: 17663720
[TBL] [Abstract][Full Text] [Related]
46. E2F-HDAC complexes negatively regulate the tumor suppressor gene ARHI in breast cancer.
Lu Z; Luo RZ; Peng H; Huang M; Nishmoto A; Hunt KK; Helin K; Liao WS; Yu Y
Oncogene; 2006 Jan; 25(2):230-9. PubMed ID: 16158053
[TBL] [Abstract][Full Text] [Related]
47. [Effect of siRNA targeting HDAC1 gene on proliferation, apoptosis, histone acetylation, and histone methylation in gastric cancer cells in vitro].
Zhuang H; Ma X; Lai Y; Xu X; Wang X
Nan Fang Yi Ke Da Xue Xue Bao; 2014 Feb; 34(2):246-50. PubMed ID: 24589606
[TBL] [Abstract][Full Text] [Related]
48. HDAC1 and 2 regulate endothelial VCAM-1 expression and atherogenesis by suppressing methylation of the
Hu C; Peng K; Wu Q; Wang Y; Fan X; Zhang DM; Passerini AG; Sun C
Theranostics; 2021; 11(11):5605-5619. PubMed ID: 33859766
[TBL] [Abstract][Full Text] [Related]
49. Epigenetic modulation of tumor suppressor CCAAT/enhancer binding protein alpha activity in lung cancer.
Tada Y; Brena RM; Hackanson B; Morrison C; Otterson GA; Plass C
J Natl Cancer Inst; 2006 Mar; 98(6):396-406. PubMed ID: 16537832
[TBL] [Abstract][Full Text] [Related]
50. The histone deacetylase inhibitor trichostatin A derepresses the telomerase reverse transcriptase (hTERT) gene in human cells.
Hou M; Wang X; Popov N; Zhang A; Zhao X; Zhou R; Zetterberg A; Björkholm M; Henriksson M; Gruber A; Xu D
Exp Cell Res; 2002 Mar; 274(1):25-34. PubMed ID: 11855854
[TBL] [Abstract][Full Text] [Related]
51. Modulation of the cyclin-dependent kinase inhibitor p21(WAF1/Cip1) gene by Zac1 through the antagonistic regulators p53 and histone deacetylase 1 in HeLa Cells.
Liu PY; Chan JY; Lin HC; Wang SL; Liu ST; Ho CL; Chang LC; Huang SM
Mol Cancer Res; 2008 Jul; 6(7):1204-14. PubMed ID: 18644983
[TBL] [Abstract][Full Text] [Related]
52. Histone deacetylase inhibitors down-regulate bcl-2 expression and induce apoptosis in t(14;18) lymphomas.
Duan H; Heckman CA; Boxer LM
Mol Cell Biol; 2005 Mar; 25(5):1608-19. PubMed ID: 15713621
[TBL] [Abstract][Full Text] [Related]
53. 5-Aza-2'-deoxycytidine (decitabine) can relieve p21WAF1 repression in human acute myeloid leukemia by a mechanism involving release of histone deacetylase 1 (HDAC1) without requiring p21WAF1 promoter demethylation.
Scott SA; Dong WF; Ichinohasama R; Hirsch C; Sheridan D; Sanche SE; Geyer CR; Decoteau JF
Leuk Res; 2006 Jan; 30(1):69-76. PubMed ID: 16043219
[TBL] [Abstract][Full Text] [Related]
54. IGF-II and IL-2 act synergistically to alter HDAC1 expression following treatments with trichostatin a.
Gray SG; Svechnikova I; Hartmann W; O'Connor L; Aguilar-Santelises M; Ekström TJ
Cytokine; 2000 Jul; 12(7):1104-9. PubMed ID: 10880258
[TBL] [Abstract][Full Text] [Related]
55. The MEF2A and MEF2D function as scaffold proteins that interact with HDAC1 or p300 in SOD3 expression in THP-1 cells.
Ichihara M; Kamiya T; Hara H; Adachi T
Free Radic Res; 2018 Jul; 52(7):799-807. PubMed ID: 29842805
[TBL] [Abstract][Full Text] [Related]
56. HDAC-mediated deacetylation of KLF5 associates with its proteasomal degradation.
Tao R; Zhang B; Li Y; King JL; Tian R; Xia S; Schiavon CR; Dong JT
Biochem Biophys Res Commun; 2018 Jun; 500(3):777-782. PubMed ID: 29679567
[TBL] [Abstract][Full Text] [Related]
57. HDAC1/HDAC3 modulates PPARG2 transcription through the sumoylated CEBPD in hepatic lipogenesis.
Lai PH; Wang WL; Ko CY; Lee YC; Yang WM; Shen TW; Chang WC; Wang JM
Biochim Biophys Acta; 2008 Oct; 1783(10):1803-14. PubMed ID: 18619497
[TBL] [Abstract][Full Text] [Related]
58. Expression levels of histone deacetylases determine the cell fate of hematopoietic progenitors.
Wada T; Kikuchi J; Nishimura N; Shimizu R; Kitamura T; Furukawa Y
J Biol Chem; 2009 Oct; 284(44):30673-83. PubMed ID: 19736310
[TBL] [Abstract][Full Text] [Related]
59. Expression profile of histone deacetylase 1 in gastric cancer tissues.
Choi JH; Kwon HJ; Yoon BI; Kim JH; Han SU; Joo HJ; Kim DY
Jpn J Cancer Res; 2001 Dec; 92(12):1300-4. PubMed ID: 11749695
[TBL] [Abstract][Full Text] [Related]
60. HDAC1-Mediated Downregulation of NEU1 Exacerbates the Aggressiveness of Cervical Cancer.
Xie N; Mei S; Dai C; Chen W
Crit Rev Eukaryot Gene Expr; 2024; 34(4):45-54. PubMed ID: 38505872
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
